In medical R&D, data without compliance is a liability. We operate with a transparency-first mandate, ensuring every record is ethically sourced and legally protected.
We utilize the "Safe Harbor" method as defined by HIPAA, coupled with additional proprietary k-anonymity protocols. All 18 Protected Health Information (PHI) identifiers are removed and verified through our internal Privacy Vault before any data is exported.
Our data governance frameworks are aligned with both **GDPR (EU)** and **CCPA (USA)**, ensuring that cross-border collaboration for global pharmaceutical projects is legally seamless. We provide comprehensive Data Processing Agreements (DPA) for all enterprise clients.
Dilisights Global only processes data from legally authorized registries, peer-reviewed open-source scientific literature, and de-identified EHR systems with proper institutional consent. We do not engage in unauthorized harvesting or process PII under any circumstances.